CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
0.88
0.04 (5.14%)
At close: Jun 27, 2025, 3:58 PM
0.88
-0.01%
After-hours: Jun 27, 2025, 05:50 PM EDT
5.14% (1D)
| Bid | 0.79 |
| Market Cap | 4.8M |
| Revenue (ttm) | 3.14K |
| Net Income (ttm) | -15.61M |
| EPS (ttm) | -924.6 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.6 |
| Analyst | Buy |
| Ask | 0.88 |
| Volume | 238,925 |
| Avg. Volume (20D) | 1,709,088 |
| Open | 0.82 |
| Previous Close | 0.84 |
| Day's Range | 0.81 - 0.90 |
| 52-Week Range | 0.73 - 148.00 |
| Beta | 0.78 |
About CNSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+12.4%
CNS Pharmaceuticals shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
-51.78%
CNS Pharmaceuticals shares are trading lower after the company announced the primary analysis of its clinical trial evaluating Berubicin for the treatment of recurrent or progressive Glioblastoma Multiforme did not demonstrate statistically significant superiority in overall survival, the primary endpoint.
